nach oben

Wiener klinische Wochenschrift

Erschienen in:

11.12.2024 | letter to the editors

Response to letter regarding article, humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity (IEI) or mannan-binding lectin (MBL) deficiency—A prospective controlled open-label trial: correspondence

verfasst von: Matthias G. Vossen, Lisa Göschl

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 1-2/2025

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Vorheriger Artikel Humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity or mannose-binding lectin deficiency: correspondence

Nächster Artikel Correction: Positionspapier der ÖGR und ÖGP zur Diagnose und Therapie der Sarkoidose 2024

van Leeuwen LPM, GeurtsvanKessel CH, Ellerbroek PM, et al. Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity. J Allergy Clin Immunol. 2022;149(6):1949–57.CrossRefPubMedPubMedCentral

Titel: Response to letter regarding article, humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity (IEI) or mannan-binding lectin (MBL) deficiency—A prospective controlled open-label trial: correspondence
verfasst von: Matthias G. Vossen
Lisa Göschl
Publikationsdatum: 11.12.2024
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 1-2/2025
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-024-02482-7

Is location more determining than WHO grade for long-term clinical outcome in patients with meningioma in the first two decades of life?

Open Access
original article

Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients

original article

Long-term results after surgical basal cell carcinoma excision in the eyelid region: revisited

Open Access
original article

Springer Medizin Österreich

Response to letter regarding article, humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity (IEI) or mannan-binding lectin (MBL) deficiency—A prospective controlled open-label trial: correspondence

Excerpt

Weitere Artikel der Ausgabe 1-2/2025

Is location more determining than WHO grade for long-term clinical outcome in patients with meningioma in the first two decades of life?

Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients

Long-term results after surgical basal cell carcinoma excision in the eyelid region: revisited

Masqueraded sebaceous gland carcinoma of the lower eyelid in a young pregnant patient

Treatment of fecal incontinence—is there a light in the end of the tunnel?

mitteilungen der gesellschaft der ärzte in wien

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Is location more determining than WHO grade for long-term clinical outcome in patients with meningioma in the first two decades of life?

Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients

Long-term results after surgical basal cell carcinoma excision in the eyelid region: revisited

Masqueraded sebaceous gland carcinoma of the lower eyelid in a young pregnant patient

Treatment of fecal incontinence—is there a light in the end of the tunnel?

mitteilungen der gesellschaft der ärzte in wien